| AMBF3 | ammonium methyltrifluoroborate |
| CT | computerized tomography |
| Dfo | desferrioxamine B |
| DOTA | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid |
| FSC | Fusarinine C |
| MMC | multimodality chelator |
| HYNIC | 6-hydrazinonicotinic acid |
| DTPA | diethylenetriaminepentaacetic acid |
| EPR | enhanced permeability and retention |
| FDG | 2-deoxy-2-fluoro-D-glucose |
| GBM | glioblastoma multiforme |
| HBED-CC | N,N′-bis-[2-hydroxy-5-(carboxyethyl)benzyl]- ethylenediamine-N,N′-diacetic acid |
| MRI | magnetic resonance imaging |
| NIR | near-infrared |
| NOTA | 1,4,7-triazacyclononane-1,4,7-triacetic acid |
| QC-1 | fluorophore quencher |
| PDT | photodynamic therapy |
| PEG | polyethylene glycol |
| PET | positron emission tomography |
| RGD | Arg-Gly-Asp |
| SPECT | single-photon computerized tomography |
| ACUPA | (N-[[[(1S)-5-Amino-1-carboxypentyl]amino]carbonyl]-L-glutamic acid |
| TOC | Tyr3-octreotide |
| IEX | isotope exchange |
| CCK2R | cholecystokinin-2 receptor |
| αVβ3 | alpha V and integrin beta 3 |
| MG11 | minigastrin analogue |
| BBN | bombesin |
| HSG | histamine–succinyl–glycine |
| PSMA | prostate specific membrane antigen |
| 5-Ala | 5-aminolevulinic acid |
| FRET | fluorescence resonance energy transfer |
| SarAr | hexaazamacrobicyclic cage ligand 1-N-(4-aminobenzyl)-3,6,10,13,16,19-hexaazabicyclo [6.6.6]eicosane-1,8-diamine |
| NETA | 2-({1-[4,7-bis(carboxymethyl)-1,4,7-triazanonan-1-yl]-7-(4-nitrophenyl)heptan-2-yl}(carboxy-methyl)amino)acetic acid |
| SSTR2 | somatostatin receptor subtype 2 |
| TF-12 | anti-TROP-2 x anti-HSG bispecific antibody |
| EGFR | epidermal growth factor receptor |
| MMP-14 | matrix metalloproteinases-14 |
| GRPR | gastrin-releasing peptide receptor |
| FGS | fluorescence-guided surgery |
| SWIR | short-wavelength infrared |
| ccRCC | clear cell renal cell carcinoma |
| VLP | virus-like particles |
| OATP | organic anion transporting polypeptide |
| DAD | donor-acceptor-donor |
| BBT | benzobis(thiadiazole) |
| CA-IX | carbonic anhydrase IX |
| cRDG | cyclic arginine-glycine-aspartic acid |
| diHSG | histamine–succinyl–glycine |
| uPAR | urokinase plasminogen activator surface receptor |
| CA19.9 | pancreatic cancer biomarker |
| EpCAM | epithelial cell adhesion molecule |
| HER2 | human epidermal growth factor 2 |
| EGFR | epidermal growth factor receptor |
| mAb | monoclonal antibody |
| CD146 | melanoma cell adhesion molecule |
| VEGF | vascular endothelial growth factor |
| CEA | carcinoembryonic antigen |
| CEACAM5 | carcinoembryonic antigen cell adhesion molecule 5 |
| Pgp | p-glycoprotein |
| TGF-β | transforming growth factor beta |
| A2cDb | A2 cys-diabody |
| PSCA | prostate stem cell antigen |